Clinical Trials Directory

Trials / Unknown

UnknownNCT02137187

Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure

A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
1,830 (estimated)
Sponsor
Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is evidence of superiority of AV junction ablation strategy over pharmacological therapy only for symptoms of atrial fibrillation, but not for heart failure, hospitalization, morbidity and mortality. Hypothesis of trial is that AV junction ablation is superior to pharmacological therapy as regard hospitalization and mortality

Detailed description

Prospective randomized, controlled, investigator-initiated trial which consists of two specific consecutive(overlapped) phases: "Morbidity trial" (APAF-CRT morbidity). Small size (280 pts), follow-up 24 months. Primary endpoint: combined of mortality due to heartfailure, hospitalization for heart failure or atrial fibrillation or worsening heart failure. Predefined subgroup analysis for patients with ejection fraction ≤35% versus \>35% "Mortality trial" (APAF-CRT mortality). Large size (pts included in morbidity trial plus additional \~1500 pts, long-term follow-up (at least 4 years). Primary endpoint: total mortality. Predefined subgroup analysis for patients with ejection fraction ≤35% versus \>35%

Conditions

Interventions

TypeNameDescription
PROCEDUREAV junction ablationAV junction ablation
DEVICECRTImplantation of device for pacing and cardiac resynchronization therapy (CRT-P or CRT-D according to guidelines)
DRUGOptimized drug therapyOptimized drug therapy for heart failure and atrial fibrillation rate control
DEVICEICDImplantable defibrillator (in control Group or in association with CRT in study Group) according to guidelines

Timeline

Start date
2014-10-15
Primary completion
2021-05-15
Completion
2021-07-31
First posted
2014-05-13
Last updated
2021-01-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02137187. Inclusion in this directory is not an endorsement.